US · Healthcare · Medical Distribution
EPS came in at 11.68 against a street estimate of 10.69 — a beat of 9.3%.
Analysts rate McKesson Corporation a buy (13 buy, 3 hold, 0 sell out of 16) with an average price target of $1,026.07.
CONFIDENT MCK beat Q1 FY27 expectations with 8% revenue growth to $105.4B and 20% EPS growth to $9.93. Raised full-year EPS guidance to $44.20–$45.00. Three segments posted double-digit profit growth; oncology surged 41% AOP. Q1 FY27 Company operates primarily in North America with portfolio actions focused on U.S. markets. Norway divestiture completed January 2026. Analysts pressed on NAP margin sustainability, O&M organic growth durability, and free cash flow lagging earnings. Management credited mix favorability, geographic expansion, and structural working capital gains; guided conservatively, not aggressively. 2026-08-05…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 9.26% |
| Vanguard Capital Management, LLC | 6.74% |
| State Street Corp | 4.91% |
| Morgan Stanley - Brokerage Accounts | 4.55% |
| Franklin Templeton Inc | 2.49% |
| Vanguard Portfolio Management, LLC | 2.46% |
| Geode Capital Management, LLC | 2.42% |
| Massachusetts Financial Services Company | 2.10% |
| Document | Date |
|---|---|
| Quarterly report · Q2 FY2027 HEADLINE NUMBERS • For the three months ended September 30, 2026, revenue was $110,957 million, up from $103,150 million in the prior-year period. • | 2026-11-04 |
| Results announced · Q3 FY2027 HEADLINE NUMBERS • Fiscal 2027 second-quarter revenue was $110,957 million, up 8% from $103,150 million. • Net income attributable to McKesson was $ | 2026-11-04 |
| Reg FD disclosure · Q3 FY2027 HEADLINE NUMBERS • McKesson filed a Form 8-K on October 6, 2026, announcing a joint news release about a proposed acquisition of Option Care Health, | 2026-10-06 |
| Reg FD disclosure · Q2 FY2027 MCKESSON CORPORATION – FORM 8-K SUMMARY Filing Date: August 28, 2026 | Event Date: August 25, 2026 --- HEADLINE NUMBERS • Company: McKESSON CORPORA | 2026-08-28 |
| Quarterly report · Q1 FY2027 MCKESSON CORPORATION – Q1 FY2027 (10-Q) SUMMARY --- HEADLINE NUMBERS • Revenues: $105,380 million (Q1 FY2027) vs. $97,827 million (Q1 FY2026) — +7. | 2026-08-05 |
| Results announced · Q2 FY2027 McKESSON CORPORATION – FISCAL 2027 Q1 RESULTS SUMMARY --- HEADLINE NUMBERS • Consolidated revenues: $105.4 billion, up 8% year-over-year • Adjusted | 2026-08-05 |
| Shareholder vote results · Q2 FY2027 MCKESSON CORPORATION FORM 8-K SUMMARY Annual Shareholder Meeting Results – July 22, 2026 --- HEADLINE NUMBERS • Total shares voted: Approximately 1 | 2026-07-24 |
| Board / officer change · Q1 FY2027 MCKESSON CORPORATION (MCK) - FORM 8-K SUMMARY HEADLINE NUMBERS • No financial metrics, earnings data, or revenue figures disclosed in this filing • D | 2026-07-01 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.94 / share ex-date Dec 1, 2026 · pay Jan 4, 2027 | 2026-12-01 |
| Dividend | $0.94 / share ex-date Sep 1, 2026 · pay Oct 1, 2026 | 2026-09-01 |
| Dividend | $0.82 / share ex-date Jun 1, 2026 · pay Jul 1, 2026 | 2026-06-01 |
| Dividend | $0.82 / share ex-date Mar 2, 2026 · pay Apr 1, 2026 | 2026-03-02 |
| Dividend | $0.82 / share ex-date Dec 1, 2025 · pay Jan 2, 2026 | 2025-12-01 |
| Announcement | Date |
|---|---|
| Proposed acquisition of Option Care Health announced McKesson, Clayton, Dubilier & Rice (CD&R), and Option Care Health announced a proposed acquisition of Option Care Health on October 6, 2026. This filing mainly provides the joint news releas | 2026-10-06 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for McKesson Corporation — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.